Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation

Clinical trial NCT06405295 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06405295
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Breast Carcinoma BRCA Mutation Adjuvant Drug Therapy

Start date: 2024-05-06
Primary completion: 2029-03-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.